Clinical Trials Sponsored by IPSOS Group S.A

Total 59 results

Dr. Lutfi Kirdar Kartal Training and Research Hospital
Turkish Endometriosis and Adenomyosis Society; IPSOS Group S.A

Completed

Menstrual Wellbeing in Woman Living in Turkey; an Epidemiological Study

Quality of Life | Menstrual Problem

Turkey
Arafarma Group, S.A.

Completed

Effects of a Food Supplement on Quality of Life in Patients With Chronic Obstructive Pulmonary Disease. (EPOCAT)

Chronic Obstructive Pulmonary Disease

Spain
Arafarma Group, S.A.

Completed

Effects of a Food Supplement in the Prevention of Urinary Tract Infections in Kidney Transplant Patients. (MANOTRAS)

Kidney Transplant Infection

Spain
Arafarma Group, S.A.

Completed

Study of the Administration of a Food Supplement in Patients With Lithiasis Treated With Extracorporeal Shock Wave Lithotripsy. (FAGOTRICIA)

Nephrolithiasis | Lithiasis

Spain
Arafarma Group, S.A.

Completed

Study of the Symptomatic Improvement in Patients With Fibromyalgia by Means of a Food Supplement (FIBROFIN)

Fibromyalgia

Spain
Nextkidney S.A.
Monitoring Force Group

Recruiting

Safety and Efficacy Assessments of NeoKidney® in ESRD Patients Treated With Short Daily Hemodialysis (FIH Caen)

End Stage Renal Disease | ESRD

France
Spanish Oncology Genito-Urinary Group
Roche Farma, S.A; Dynamic Science S.L.

Active, not recruiting

Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer

Bladder Cancer

Spain
AgNovos Healthcare, LLC
KCR S.A.; genae Group

Completed

CONFIRM - Study of AGN1 LOEP in Patients With Osteoporosis

Osteoporosis

Belgium, Netherlands
Mesoestetic Pharma Group S.L.

Completed

Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina.

Urinary Incontinence | Vaginal Atrophy | Vulvovaginal Signs and Symptoms | Dyspareunia

Bulgaria
Arafarma Group, S.A.
Fundación Teófilo Hernando, Spain

Completed

Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.

Diabetic Neuropathy, Painful
Mesoestetic Pharma Group S.L.

Completed

Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy

Facial Rejuvenation

Bulgaria
Mesoestetic Pharma Group S.L.

Completed

Clinical Investigation to Assess Safety and Performance of Dermal Filler of Hyaluronic Acid

Wrinkle | Skin Folds

Spain
Mesoestetic Pharma Group S.L.

Completed

Evaluation of the Efficacy and Safety of the Dermal Filler for Augmentation of Labia Majora.

Labia Majora Atrophy and Hypotrophy

Bulgaria
Mesoestetic Pharma Group S.L.

Completed

Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma

Facial Melasma

Spain
Spanish Breast Cancer Research Group
Roche Farma, S.A

Completed

Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA) (KATIA)

Advanced Breast Cancer

Spain
Spanish Breast Cancer Research Group
Roche Farma, S.A

Completed

Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal Cancer (BRECOL)

Metastatic Colorectal Cancer | Metastatic Breast Cancer

Spain
Spanish Breast Cancer Research Group
Roche Farma, S.A

Completed

Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis

Breast Cancer

Spain
Laboratorios del Dr. Esteve, S.A.
Premier Research Group plc

Completed

Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial.

Acute Post-surgical Pain

United States
Laboratórios Baldacci S.A
Opera CRO, a TIGERMED Group Company

Completed

Performance and Tolerability of the Medical Device LACRIACT

Dry Eye | Photophobia | Contact Lens Acute Red Eye | Discomfort

Italy
Spanish Cooperative Group for the Treatment of...
Merck, S.L., Spain; Pierre Fabre Ibérica, S.A.

Not yet recruiting

Study to Evaluate the Efficacy and Safety of Cetuximab in Combination With Encorafenib Plus Binimetinib as Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer (CEBBRA)

Colorectal Cancer
Epitech Group SpA
Azienda Ospedaliera "Sant'Andrea"

Completed

Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients

Covid19

Italy
Mesoestetic Pharma Group S.L.
Opera CRO, a TIGERMED Group Company

Completed

Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation

Facial Rejuvenation

Romania
Aboca Spa Societa' Agricola
GB Pharma Group

Completed

Effectiveness & Safety of Neofitoroid® in Hemorrhoidal Disease

Hemorrhoids

Italy
Spanish Breast Cancer Research Group
Hoffmann-La Roche; Roche Farma, S.A

Terminated

A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer

Breast Cancer Invasive Nos

Spain
Spanish Oncology Genito-Urinary Group
Pivotal S.L.

Active, not recruiting

Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer (QRT-SOGUG)

Prostate Cancer Stage III | Prostate Cancer Stage IV
Neurology Group of Bergen County, P.A.
Shire

Completed

Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine

Attention-deficit/Hyperactivity Disorder

United States
Icahn School of Medicine at Mount Sinai
Neuro Device Group S.A.

Recruiting

Neuro Device for Aphasia

Post-stroke Aphasia

United States
TcLand Expression S.A.
Premier Research Group plc; Theradis pharma; Medpharmgene, Inc.

Terminated

Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy (PRINT)

Rheumatoid Arthritis

Canada, France, Hungary, Italy, Lithuania, Romania, Slovakia, Spain
Epitech Group SpA
Azienda Ospedaliera Universitaria Integrata Verona

Completed

Micronized and Ultramicronized Palmitoylethanolamide in Fibromyalgia Patients

Fibromyalgia

Italy
SIFI SpA
Opera CRO, a TIGERMED Group Company

Completed

Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens (PSM15)

Cataract | Presbyopia

Germany
AI Labs Group S.L
University Hospital of Torrejon

Completed

Clinical Validation of AI-Based System for Continuous Remote Monitoring of Patient Severity (COVIDX_EVCDAO)

Skin Diseases | Skin Condition

Spain
SIFI SpA
Opera CRO, a TIGERMED Group Company

Completed

The Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus

Cataract | Presbyopia

Italy
SIFI SpA
Opera CRO, a TIGERMED Group Company

Terminated

Non-Inferiority Study Comparing MINI WELL READY® and FineVision® in Patients With Cataract Surgery

Cataract | Presbyopia

France
Bio Sidus SA
IC RESEARCH GROUP

Completed

Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia

Antineoplastic Chemotherapy Induced Anemia

Argentina
Spanish Oncology Genito-Urinary Group
Apices Soluciones S.L.

Completed

Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study (CABOMAYOR)

Old Age; Debility | Renal Carcinoma Metastatic

Spain
SIFI SpA
Opera CRO, a TIGERMED Group Company

Completed

Trial Following Subjects Bilaterally Implanted With Mini Well Ready For 2 Years After the Second Eye Implant

Cataract

Italy
Groupe Francophone des Myelodysplasies
Advancell - Advanced In Vitro Cell Technologies, S.A.

Terminated

GFM-Acadesine: A Phase I-II Trial of Acadesine (Acadesine)

SMD

France
AI Labs Group S.L
Instituto de Dermatología Integral (IDEI)

Recruiting

Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions (IDEI_2023)

Acne Vulgaris | Acne | Alopecia, Androgenetic | Pigmented Lesions | Pigmented Skin Lesion

Spain
Spanish Oncology Genito-Urinary Group
AstraZeneca; Apices Soluciones S.L.

Completed

Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL) (IMANOL)

Prostate Cancer Metastatic

Spain
Ontario Clinical Oncology Group (OCOG)
Aboca Spa Societa' Agricola

Completed

Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population (ABOCA1)

Asbestos Exposure

Canada
Pharnext SA
Ascopharm Groupe Novasco

Completed

24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion (PLEODIAL-II)

Alzheimer Disease

France
Spanish Oncology Genito-Urinary Group
Pfizer; Apices Soluciones S.L.

Completed

Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment. (INMUNOSUN)

Clear Cell Renal Carcinoma

Spain
Pharnext SA
Ascopharm Groupe Novasco

Completed

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD) (PLEODIAL-I)

Alzheimer Disease

France
Spanish Oncology Genito-Urinary Group
Ipsen; Syntax for Science, S.L

Completed

Spanish Real-World Evidence Cabozantinib (SRWEC)

Renal Cell Carcinoma

Spain
Spanish Oncology Genito-Urinary Group
Apices Soluciones S.L.; Janssen, LP

Completed

Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer. (ABIDO)

Metastatic Prostate Cancer

Spain
Effik SA
Opera CRO, a TIGERMED Group Company

Not yet recruiting

Prevalence and Burden of Nausea and Vomiting in Pregnant Women in Switzerland: Survey Purity 2022

Nausea | Vomiting of Pregnancy
Spanish Oncology Genito-Urinary Group
AstraZeneca; Apices Soluciones S.L.; Sistemas Genómicos

Completed

Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB) (NEODURVARIB)

Bladder Cancer

Spain
University Hospital, Brest
Roche Farma, S.A; Pierre Fabre Medicament; Groupe Français de Pneumo-Cancérologie

Completed

Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer (VinMetAtezo)

Non-small Cell Lung Cancer

France
Spanish Oncology Genito-Urinary Group
Astellas Pharma Inc; Apices Soluciones S.L.

Completed

Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer (PREMIERE)

Hormone-refractory Prostate Cancer

Spain
ADDMEDICA SASA
Simbec-Orion Group; PhinC Development; Oncodesign SA

Completed

A Bioequivalence Study to Compare the Pharmacokinetics of Two Formulations of Siklos® in Healthy Volunteers

Healthy Volunteers

United Kingdom

Clinical Trials Sponsored by IPSOS Group S.A

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations